The Role of Combination Chemotherapy in the Treatment of Patients with Metastatic Breast Cancer

by Huober, Jens, Thürlimann, Beat
Published 2009

Adjuvant Bisphosphonates in Breast Cancer Treatment

by Knauer, Michael, Thürlimann, Beat
Published in Breast Care (Basel) (2014)

Bone Targeted Therapy in Breast Cancer – an Old Concept but Still Much to Do

by Huober, Jens, Thürlimann, Beat
Published in Breast Care (Basel) (2014)

ASCO 2009: What's New in Breast Cancer Therapy?

by Biganzoli, Laura, Bonnefoi, Hervé, Cardoso, Fatima, Coleman, Robert, Thürlimann, Beat
Published 2009

Management of HER2-Positive Early Breast Cancer

by Steger, Günther, Lüftner, Diana, Stöger, Herbert, Thürlimann, Beat, Untch, Michael
Published in Breast Care (Basel) (2018)

Screening is associated with lower mastectomy rates in eastern Switzerland beyond stage effects

by Herrmann, Christian, Morant, Rudolf, Walser, Esther, Mousavi, Mohsen, Thürlimann, Beat
Published in BMC Cancer (2021)

40 years of progress in female cancer death risk: a Bayesian spatio-temporal mapping analysis in Switzerland

by Herrmann, Christian, Ess, Silvia, Thürlimann, Beat, Probst-Hensch, Nicole, Vounatsou, Penelope
Published in BMC Cancer (2015)

Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies

by Herrmann, Christian, Vounatsou, Penelope, Thürlimann, Beat, Probst-Hensch, Nicole, Rothermundt, Christian, Ess, Silvia
Published in BMJ Open (2018)

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal w...

by Regan, Meredith M, Price, Karen N, Giobbie-Hurder, Anita, Thürlimann, Beat, Gelber, Richard D
Published 2011

Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early br...

by Maranta, Angela Fischer, Broder, Simon, Fritzsche, Constanze, Knauer, Michael, Thürlimann, Beat, Jochum, Wolfram, Ruhstaller, Thomas
Published in Breast (2020)

Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors

by Templeton, Arnoud J, Thürlimann, Beat, Baumann, Michael, Mark, Michael, Stoll, Sarah, Schwizer, Madeleine, Dietrich, Daniel, Ruhstaller, Thomas
Published 2013

Integration of Clinical Variables for the Prediction of Late Distant Recurrence in Patients With Estrogen Receptor–Positive Breast Cancer Treated With 5 Years of Endocrine Therapy:...

by Dowsett, Mitch, Sestak, Ivana, Regan, Meredith M., Dodson, Andrew, Viale, Giuseppe, Thürlimann, Beat, Colleoni, Marco, Cuzick, Jack
Published in J Clin Oncol (2018)

Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99

by Eppenberger-Castori, Serenella, Klingbiel, Dirk, Ruhstaller, Thomas, Dietrich, Daniel, Rufle, Daniel Alexander, Rothgiesser, Karin, Pagani, Olivia, Thürlimann, Beat
Published in BMC Cancer (2020)

Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study

by Varga, Zsuzsanna, Cassoly, Estelle, Li, Qiyu, Oehlschlegel, Christian, Tapia, Coya, Lehr, Hans Anton, Klingbiel, Dirk, Thürlimann, Beat, Ruhstaller, Thomas
Published in PLoS One (2015)

Pharmacokinetics of Selected Anticancer Drugs in Elderly Cancer Patients: Focus on Breast Cancer

by Crombag, Marie-Rose B.S., Joerger, Markus, Thürlimann, Beat, Schellens, Jan H.M., Beijnen, Jos H., Huitema, Alwin D.R.
Published in Cancers (Basel) (2016)

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

by Chirgwin, Jacquie, Sun, Zhuoxin, Smith, Ian, Price, Karen N., Thürlimann, Beat, Ejlertsen, Bent, Bonnefoi, Hervé, Regan, Meredith M., Goldhirsch, Aron, Coates, Alan S.
Published in Breast Cancer Res Treat (2011)

Adjuvant!(©) Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breas...

by Paridaens, Robert J., Gelber, Shari, Cole, Bernard F., Gelber, Richard D., Thürlimann, Beat, Price, Karen N., Holmberg, Stig B., Crivellari, Diana, Coates, Alan S., Goldhirsch, Aron
Published 2010

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

by Colleoni, Marco, Sun, Zhuoxin, Price, Karen N., Karlsson, Per, Forbes, John F., Thürlimann, Beat, Gianni, Lorenzo, Castiglione, Monica, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron
Published in J Clin Oncol (2016)

Independent Validation of EarlyR Gene Signature in BIG 1-98: A Randomized, Double-Blind, Phase III Trial Comparing Letrozole and Tamoxifen as Adjuvant Endocrine Therapy for Postmen...

by Buechler, Steven A, Gray, Kathryn P, Gökmen-Polar, Yesim, Willis, Scooter, Thürlimann, Beat, Kammler, Rosita, Viale, Giuseppe, Leyland-Jones, Brian, Badve, Sunil S, Regan, Meredith M
Published in JNCI Cancer Spectr (2019)

Molecular risk assessment of BIG 1-98 participants by expression profiling using RNA from archival tissue

by Antonov, Janine, Popovici, Vlad, Delorenzi, Mauro, Wirapati, Pratyaksha, Baltzer, Anna, Oberli, Andrea, Thürlimann, Beat, Giobbie-Hurder, Anita, Viale, Giuseppe, Altermatt, Hans Jörg, Aebi, Stefan, Jaggi, Rolf
Published 2010